UnitedHealth Group Inc (NYSE:UNH) – Research analysts at Cantor Fitzgerald upped their FY2018 EPS estimates for shares of UnitedHealth Group in a report released on Wednesday, according to Zacks Investment Research. Cantor Fitzgerald analyst S. Halper now forecasts that the healthcare conglomerate will post earnings per share of $12.40 for the year, up from their previous estimate of $10.80. Cantor Fitzgerald currently has a “Overweight” rating and a $280.00 target price on the stock.
A number of other research firms have also recently commented on UNH. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 price objective on the stock in a report on Saturday, January 20th. Argus upped their price objective on UnitedHealth Group to $270.00 and gave the company a “buy” rating in a report on Thursday, January 18th. Deutsche Bank upped their price objective on UnitedHealth Group to $260.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Citigroup upped their price objective on UnitedHealth Group from $235.00 to $268.00 and gave the company a “buy” rating in a report on Wednesday, January 17th. Finally, Piper Jaffray Companies reiterated a “buy” rating and issued a $259.00 price objective on shares of UnitedHealth Group in a report on Wednesday, January 17th. Two investment analysts have rated the stock with a hold rating and twenty-six have given a buy rating to the company. The stock currently has an average rating of “Buy” and a consensus price target of $243.22.
UnitedHealth Group (NYSE UNH) opened at $225.69 on Friday. The firm has a market capitalization of $218,710.00, a P/E ratio of 21.07, a PEG ratio of 1.29 and a beta of 0.70. UnitedHealth Group has a twelve month low of $156.49 and a twelve month high of $250.79. The company has a current ratio of 0.73, a quick ratio of 0.70 and a debt-to-equity ratio of 0.58.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $2.50 by $0.09. The business had revenue of $52.06 billion for the quarter, compared to analysts’ expectations of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. The business’s revenue for the quarter was up 9.5% compared to the same quarter last year. During the same period in the previous year, the firm posted $2.11 EPS.
In other news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction on Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the sale, the director now owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Michele J. Hooper sold 10,000 shares of the company’s stock in a transaction on Wednesday, January 31st. The stock was sold at an average price of $237.76, for a total value of $2,377,600.00. Following the sale, the director now directly owns 37,284 shares in the company, valued at approximately $8,864,643.84. The disclosure for this sale can be found here. In the last three months, insiders sold 53,396 shares of company stock worth $12,262,067. 0.89% of the stock is owned by corporate insiders.
Several institutional investors have recently bought and sold shares of UNH. Covenant Asset Management LLC increased its holdings in UnitedHealth Group by 2.7% in the second quarter. Covenant Asset Management LLC now owns 7,185 shares of the healthcare conglomerate’s stock valued at $1,332,000 after buying an additional 190 shares during the last quarter. ETF Portfolio Partners Inc. purchased a new position in UnitedHealth Group in the second quarter valued at $206,000. Central Bank & Trust Co. increased its holdings in UnitedHealth Group by 0.8% in the second quarter. Central Bank & Trust Co. now owns 17,992 shares of the healthcare conglomerate’s stock valued at $3,336,000 after buying an additional 134 shares during the last quarter. Johanson Financial Advisors Inc. increased its holdings in UnitedHealth Group by 4.4% in the second quarter. Johanson Financial Advisors Inc. now owns 6,802 shares of the healthcare conglomerate’s stock valued at $1,264,000 after buying an additional 285 shares during the last quarter. Finally, Appleton Partners Inc. MA increased its holdings in UnitedHealth Group by 1.1% in the second quarter. Appleton Partners Inc. MA now owns 29,919 shares of the healthcare conglomerate’s stock valued at $5,548,000 after buying an additional 339 shares during the last quarter. 86.00% of the stock is currently owned by institutional investors and hedge funds.
ILLEGAL ACTIVITY WARNING: This story was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of US & international copyright legislation. The correct version of this story can be read at https://www.dispatchtribunal.com/2018/02/13/unitedhealth-group-inc-unh-forecasted-to-earn-fy2018-earnings-of-12-40-per-share.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Get a free copy of the Zacks research report on UnitedHealth Group (UNH)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.